Sinopharm Group Co. Ltd (X2S) — Long-term Investment Intensity
Sinopharm Group Co. Ltd (X2S) has a Long-term Investment Intensity of 2.6% as of September 2019. Long-term investments of €7.61 Billion represent 2.6% of total assets of €287.01 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check X2S financial resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Sinopharm Group Co. Ltd Long-term Investment Intensity (2013–2018)
This chart shows how Sinopharm Group Co. Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2018. As of September 2019, the intensity stands at 2.6%, reflecting long-term investments of €7.61 Billion against total assets of €287.01 Billion EUR. For the complete balance sheet picture, see Sinopharm Group Co. Ltd (X2S) total assets.
Annual Long-term Investment Intensity for Sinopharm Group Co. Ltd (2013–2018)
The table below presents the year-by-year Long-term Investment Intensity for Sinopharm Group Co. Ltd from 2013 to 2018, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Sinopharm Group Co. Ltd (X2S) total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 3.0% | €7.07 Billion | €235.77 Billion | ▼ -0.7 pp |
| 2017 | 3.7% | €6.28 Billion | €169.54 Billion | ▲ +1.3 pp |
| 2016 | 2.4% | €3.79 Billion | €157.71 Billion | ▲ +1.4 pp |
| 2015 | 1.0% | €1.46 Billion | €139.43 Billion | ▲ +0.1 pp |
| 2014 | 1.0% | €1.28 Billion | €128.66 Billion | ▲ +0.0 pp |
| 2013 | 1.0% | €1.01 Billion | €105.45 Billion | — |